NOCTRIX HEALTH SECURES $40 MILLION SERIES C FINANCING TO COMMERCIALIZE NOVEL DEVICE TREATMENT FOR RESTLESS LEGS SYNDROME (RLS)

PLEASANTON, Calif., Jan. 16, 2024 /PRNewswire/ — Noctrix Health, Inc. announced today that it has closed a $40M Series C financing round led by Sectoral Asset Management with participation from other new investors Angelini Ventures, ResMed, and Asahi Kasei Corporation with strong support…

Click here to view original post